Related Experiment Video
Updated: Jan 17, 2026
03:33
Author Spotlight: Advancing Hepatobiliary and Pancreatic Tumor Treatment with Minimally Invasive Surgical Techniques
Published on: September 27, 2024
1.4K
A long journey with minimally invasive surgery
Youngjin Kim1, Seung-Yong Jeong1,2,3,4
1Department of Surgery, Seoul National University Hospital, Seoul, Korea.
Journal of Minimally Invasive Surgery
|September 15, 2025
Summary
Minimally invasive surgery (MIS) has revolutionized surgical oncology, with Korea leading advancements in colorectal procedures from laparoscopy to robotics. Continued research and clinical trials are crucial for evidence-based innovation in MIS.
Area of Science:
- Surgical Oncology
- Minimally Invasive Surgery (MIS)
Background:
- Minimally invasive surgery (MIS) has significantly impacted surgical oncology over 40 years.
- Korea has played a pivotal role in the adoption and advancement of MIS techniques.
Purpose of the Study:
- To review the evolution of MIS in Korea, focusing on colorectal surgery.
- To highlight key milestones, challenges, and future directions in MIS.
- To emphasize the importance of evidence-based innovation and clinical trials.
Main Methods:
- Narrative review based on personal experience and institutional history.
- Discussion of landmark clinical trials, including the COREAN trial.
- Analysis of the progression from laparoscopic cholecystectomy to robotic surgery.
Main Results:
- Korea has a pioneering history in MIS, particularly in advanced colorectal procedures.
- The evolution spans from basic laparoscopic techniques to complex robotic-assisted surgeries.
- Landmark trials like COREAN have contributed significantly to the evidence base.
Conclusions:
- Sustained commitment to clinical trials is essential for advancing MIS.
- Evidence-based surgical innovation is critical for the future of surgical oncology.
- MIS continues to transform patient care in surgical oncology.
